Navigation Links
Wound Management Technologies, Inc. Announced Today That It Has Reached an Agreement in Principal to Acquire BioPharma Management Technologies, Inc.
Date:6/16/2009

FORT WORTH, Texas, June 16 /PRNewswire/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (WNDM.OB), announced today that it has reached an agreement in principle to acquire BioPharma Management Technologies, Inc., a privately held biotechnology company with a platform of proprietary and patented technologies for topical pain management and resorbable orthoses. The transaction would be structured as a share exchange pursuant to which BioPharma would become a wholly owned subsidiary of Wound Management in exchange for 5,000,000 shares of Wound Management common stock. The transaction is subject to certain contingencies, including a complete legal, financial and technical review of BioPharma by Wound Management.

"We believe that BioPharma's proprietary technologies and its future products will be complementary to CellerateRx and will provide a broad application across several of the medical markets that we currently serve," said Mr. Scott Haire, Wound Management's Chief Executive Officer. "We have been focused on bringing the science and technology of CellerateRx to the market over the past year, and we believe that the additional science and technology behind BioPharma would solidify Wound Management as a leading provider of wound care products."

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at www.Celleraterx.com .

About BioPharma Management Technologies, Inc.:

BioPharma is a biote
'/>"/>

SOURCE Wound Management Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hill-Rom Innovative Envision(R) E700 Wound Surface Receives Gold Medical Device Excellence Award
2. NeoStem Obtains Exclusive Worldwide License for Innovative Stem Cell Technology and Applications to Heal Chronic Wounds
3. ULURU to Present Clinical Evidence and Advanced Research on Altrazeal at the Society for Advance Wound Care Conference for 2009
4. Environmental Tectonics Corporation Exhibiting at the Annual Symposium on Advanced Wound Care and Wound Healing Society
5. Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher
6. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
7. Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma
8. Wound Management Technologies, Inc. Announces a Published Case Study
9. Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123
10. Derma Sciences Announces Multiple Clinical Posters Featuring MEDIHONEY(R) and ALGICELL Ag(R) to be Presented at Upcoming Wound Care Conference
11. Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ICAGO, Nov. 30 Dr. Jessica Torrent...ington University Medical Center in Washington, D....-Specific Gamma Imaging (BSGI) in clinical practic... of breast cancer today at the annual meeting of t..., "The purpose of the exhibit was to demonstrat...
(Date:11/30/2009)..., SEATTLE, Nov. 30 Ce... announced today that its new class of platinum-ba...emonstrated a stronger anti-tumor potency and acti...d compounds as well as the ability to overcome cis...ts were presented in a paper titled "Novel Bis-pla...
(Date:11/29/2009)...se is available in German . , The concept o...n physics. The most famous example is that of quar...s. Now Prof. Bella Lake from Helmholtz-Zentrum Ber...sts report for the first time an experimental real...rved in a condensed matter system. , The concept...
(Date:11/26/2009)...FAYETTE, Ind. - A new generation of ultrasmall tra...ny structures called semiconducting nanowires are ...hers at IBM, Purdue University and the University ...have learned how to create nanowires with layers o...the atomic level, which is a critical requirement ...
Breaking Biology Technology:Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Spinons -- confined like quarks 2Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3
...., Feb. 20 InterMune, Inc. (Nasdaq: ITMN ) anno...d full-year 2008 financial results on Thursday, Fe... conference call and webcast will be hosted by Int... , To access the live teleconference, dial 888-79...ference ID# 86755415. To access the webcast, plea...
...The Netherlands, February 20 Nyenrode Business,Un...to Professor Michael,Porter, icon in the field of ...heory. Professor Porter is generally considered as...e world,s most influential thought leader in the,f...ssor Porter will receive,the Honorary Doctorate on...
...fety Study in Patients with Severe Post-Operative ...its and Support NDA Submission , , SYDNEY and BED...X and OTCQX: QRXPY), a clinical-stage specialty ph...d commercialisation of therapies for pain and cent...y the initiation of a comparative 3-arm pilot stud...
Other Biology Technology:InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26 2Nyenrode Honorary Doctorate for Professor Michael E. Porter 2QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy 2QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy 3QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy 4
(Date:11/30/2009)...a colorless and odorless radioactive gas that is p... is a product of uranium decay and is found in tra...nd groundwater as well as building materials, plan...tration is expressed as the amount of radiation th...s in a liter of air; thus the units are picocuries...
(Date:11/26/2009)...have at last worked out a way of using recordings ... populations. This is the first time sound recordi...nto accurate estimates of bird species, population...ish Ecological Society,s Journal of Applied Ecolo... to a major advance in our ability to monitor whal...
(Date:11/26/2009)...erg, 27 November 2009 What are the bare essential...to produce a cell that can survive on its own? Can...understand how an entire organism functions as a s...cientists in a partnership between the European Mo...ermany, and the Centre de Regulacio Genmica (CRG) ...
Breaking Biology News(10 mins):Health Physics Society recommends considering action for indoor radon below current guidelines 2Ecologists sound out new solution for monitoring cryptic species 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 1New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 2New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 3New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 4New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting Edge Treatment to Satellite Communities 56758 5Tetraphase Presents Study Results for Novel Classes of Antibiotics from its Breakthrough Synthetic Chemistry Platform at ICAAC 2009 13979 1Tetraphase Presents Study Results for Novel Classes of Antibiotics from its Breakthrough Synthetic Chemistry Platform at ICAAC 2009 13979 2Video 3A U S Department of Health and Human Services Joins Ad Council and Warner Bros Pictures to Combat Childhood Overweight and Obesity 56755 1Video 3A U S Department of Health and Human Services Joins Ad Council and Warner Bros Pictures to Combat Childhood Overweight and Obesity 56755 2Video 3A U S Department of Health and Human Services Joins Ad Council and Warner Bros Pictures to Combat Childhood Overweight and Obesity 56755 3Video 3A U S Department of Health and Human Services Joins Ad Council and Warner Bros Pictures to Combat Childhood Overweight and Obesity 56755 4Video 3A U S Department of Health and Human Services Joins Ad Council and Warner Bros Pictures to Combat Childhood Overweight and Obesity 56755 5
...are the first to create a large-scale, cell-based ...ctivate immune-response cells that hold promise fo...ning technique can scan thousands and even million...dritic cells, which are on constant recon patrol t...ted cells and alert the immune system. , "Our ass...
...itoes that helps the insects to fight off infectio... in humans. Anopheles mosquitoes transmit the mala...e each year with these cases resulting in more tha...as identified in a study conducted by a team of in...l of Public Health,s Malaria Research Institute, t...
...ia, private practice, government and industry are ... symposium in interventional oncology, a rapidly g...ve interventional radiology treatments for cancer....tments for liver, kidney, bone and lung tumors. Th...ty for cross-fertilization between researchers in ...
Other Biology News:UT Southwestern researchers develop screening test for cells that activate immune system 2Gene that helps mosquitoes fight off malaria parasite identified 2Minimally Invasive Cancer Treatments Highlighted 2Minimally Invasive Cancer Treatments Highlighted 3
Mouse Anti-JNK2 Antibody, Unconjugated from Upstate
...: Synthetic peptide derived from the C-terminal re...ase C zeta isoform (PKCzeta). Specificity: Reacts...es PKCzeta and PKMzeta (PKCzeta II) and does not c... Rat (positive controls: mouse and rat kidney and ...
GIBCO AlbuMAX II from Invitrogen
GIBCO Dulbecco's Phosphate-Buffered Saline (D-PBS) (1X) liquid from Invitrogen
Biology Products: